ProfileGDS4718 / 227949_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 4% 6% 14% 6% 4% 43% 17% 5% 6% 6% 1% 7% 9% 49% 4% 6% 6% 22% 3% 9% 4% 14% 5% 5% 10% 83% 7% 72% 1% 27% 4% 24% 12% 5% 48% 33% 27% 6% 7% 12% 6% 26% 40% 13% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]3.540754
GSM549102patient 115, normal, homogenized [OPG study]3.651326
GSM549104patient 119, normal, homogenized [OPG study]3.8871314
GSM549108patient 138, normal, homogenized [OPG study]3.627896
GSM549119patient 077, normal, homogenized [OPG study]3.512064
GSM549133patient 032, cancer, homogenized [OPG study]5.0866143
GSM549139patient 042, cancer, homogenized [OPG study]4.0084717
GSM549099patient 107, normal, homogenized [OPG study]3.566685
GSM549109patient 139, normal, homogenized [OPG study]3.661926
GSM549110patient 046, normal, homogenized [OPG study]3.622756
GSM549114patient 063, normal, homogenized [OPG study]3.284141
GSM549122patient 082, normal, homogenized [OPG study]3.681677
GSM549134patient 033, cancer, homogenized [OPG study]3.753049
GSM549136patient 036, cancer, homogenized [OPG study]5.4242549
GSM549140patient 044, cancer, homogenized [OPG study]3.504544
GSM549111patient 047, normal, homogenized [OPG study]3.599996
GSM549113patient 057, normal, homogenized [OPG study]3.614596
GSM549132patient 031, cancer, homogenized [OPG study]4.2250122
GSM549137patient 038, cancer, homogenized [OPG study]3.513263
GSM549142patient 047, cancer, homogenized [OPG study]3.792299
GSM549100patient 110, normal, homogenized [OPG study]3.512084
GSM549107patient 135, normal, homogenized [OPG study]3.8862514
GSM549115patient 068, normal, homogenized [OPG study]3.564245
GSM549116patient 072, normal, homogenized [OPG study]3.577375
GSM549120patient 078, normal, homogenized [OPG study]3.790210
GSM549131patient 030, cancer, homogenized [OPG study]8.2782883
GSM549118patient 074, normal, homogenized [OPG study]3.666147
GSM549129patient 027, cancer, homogenized [OPG study]7.1520972
GSM549123patient 088, normal, homogenized [OPG study]3.381641
GSM549124patient 006, cancer, homogenized [OPG study]4.4462427
GSM549126patient 015, cancer, homogenized [OPG study]3.522164
GSM549128patient 025, cancer, homogenized [OPG study]4.2899924
GSM549103patient 117, normal, homogenized [OPG study]3.8617812
GSM549117patient 073, normal, homogenized [OPG study]3.60415
GSM549138patient 041, cancer, homogenized [OPG study]5.3748948
GSM549141patient 045, cancer, homogenized [OPG study]4.6041633
GSM549130patient 028, cancer, homogenized [OPG study]4.4391227
GSM549101patient 111, normal, homogenized [OPG study]3.633826
GSM549105patient 128, normal, homogenized [OPG study]3.678237
GSM549106patient 134, normal, homogenized [OPG study]3.8132812
GSM549112patient 048, normal, homogenized [OPG study]3.615346
GSM549125patient 011, cancer, homogenized [OPG study]4.3738426
GSM549127patient 024, cancer, homogenized [OPG study]4.9775140
GSM549135patient 035, cancer, homogenized [OPG study]3.8526813